WM Technology Reports Revenue Decline Amid Cannabis Market Softness

Event summary

  • Q1 2026 revenue declined to $43.6M from $44.6M in the prior year period.
  • Average monthly paying clients decreased to 4,983 from 5,179 due to churn in established markets.
  • Average monthly revenue per paying client increased to $2,914 from $2,871.
  • Net income decreased to $1.7M from $2.5M in the prior year period.
  • Adjusted EBITDA decreased to $5.9M from $10.1M in the prior year period.

The big picture

WM Technology's Q1 2026 results reflect the broader challenges facing the cannabis industry, including regulatory uncertainty and market softness. The company's focus on disciplined expense management and product enhancements highlights its strategic response to a difficult operating environment. The federal rescheduling of medical cannabis represents a potential long-term positive, but its immediate impact remains unclear.

What we're watching

Regulatory Impact
How the federal rescheduling of medical cannabis will affect WM Technology's business and the broader cannabis ecosystem.
Market Recovery
Whether WM Technology can sustain revenue growth amid continued softness in core markets.
Operational Efficiency
The pace at which WM Technology can align its cost structure with the current operating environment.